Pharmaceutical pricing projects and consulting
“Expert-led MFN assessments, international reference pricing analysis and launch strategy delivered in SyMAP.”
Symaptics
“Symaptics builds SyMAP, a pharmaceutical pricing and market access platform covering international reference pricing simulation, US Most Favored Nation policy modelling, and global revenue forecasting and optimisation. London based, founded by pharmaceutical pricing specialists.”
Products & services
Questions & answers
Do we need a SyMAP licence?
“No. You can commission a project on its own. A licence is optional if you want your team to edit and rerun models afterwards.”
How long does a project take?
“Timing depends on the portfolio, markets, scenarios and available data. We agree a timescale when we scope the project.”
What access do we get to the model?
“You receive access to view and explore the project simulations in SyMAP. Editing and rerunning those models requires a subsequent platform licence.”
Can you use our existing data?
“Yes. We can start with your price files, forecasts and assumptions, or source and build reference data. The inputs remain visible in the analysis.”
Can you review analysis we already have?
“Yes. We can independently rebuild an analysis to investigate differences between models or check a result before it reaches a decision-making meeting.”
Data formats & record details
Download this profile and inspect its supporting evidence.
- Entity ID
- urn:readyscan:entity:symaptics-q140724419
- Material fingerprint
- fnv1a64:a309a7be66ad5efa
- Entity revision
- fnv1a64:4b01929db5101198
- Published
- 2026-10-20
- Modified
- 2026-10-20
- Source summary
- Symaptics: “Symaptics builds SyMAP, a pharmaceutical pricing and market access platform covering international reference pricing simulation, US Most Favored Nation policy modelling, and global revenue forecasting and optimisation. London based, founded by pharmaceutical pricing specialists.”